Publication:
Association of calcium antagonist use with lower hemoglobin levels in hemodialysis patients

Simple item page
dc.contributor.authorCIKRIKCIOGLU, M. A.
dc.contributor.authorOZDEMIR, A. A.
dc.contributor.authorSEKIN, Y.
dc.contributor.authorYALCIN, BURAK
dc.contributor.authorALTAY, M.
dc.contributor.authorGUNDOGDU, A.
dc.contributor.authorErkal, S. N.
dc.contributor.authorKazancioglu, RÜMEYZA
dc.contributor.authorERKOC, R.
dc.contributor.institutionauthorYALÇIN, BURAK
dc.contributor.institutionauthorKAZANCIOĞLU, RÜMEYZA
dc.date.accessioned2019-10-05T21:40:54Z
dc.date.available2019-10-05T21:40:54Z
dc.date.issued2015-09-01
dc.description.abstractAim. Objective of the present study was to investigate whether calcium antagonist use is associated with lower hemoglobin levels and/or higher erythropoiesis stimulating agent (ESA) requirement in hemodialysis patients.
dc.identifier10.4067/s0717-95022017000401416
dc.identifier.citationCIKRIKCIOGLU M. A. , OZDEMIR A. A. , SEKIN Y., YALCIN B., ALTAY M., GUNDOGDU A., Erkal S. N. , Kazancioglu R., ERKOC R., -Association of calcium antagonist use with lower hemoglobin levels in hemodialysis patients-, MINERVA UROLOGICA E NEFROLOGICA, cilt.67, ss.187-196, 2015
dc.identifier.pubmed26197790
dc.identifier.scopus85021849772
dc.identifier.urihttps://hdl.handle.net/20.500.12645/7942
dc.identifier.wosWOS:000363830400003
dc.language.isoen
dc.titleAssociation of calcium antagonist use with lower hemoglobin levels in hemodialysis patients
dc.typeArticle
dspace.entity.typePublication
local.article.journalnameINTERNATIONAL JOURNAL OF MORPHOLOGY
local.avesis.idc55493bf-870c-4c23-b602-f12efb3a8971
local.avesis.response7818
local.publication.isinternational1
relation.isAuthorOfPublicatione62adf0c-ddae-40b9-900e-33c2975fd3ae
relation.isAuthorOfPublicationeca7bd30-6b6e-444d-96ae-2961c39f2107
relation.isAuthorOfPublication.latestForDiscoveryeca7bd30-6b6e-444d-96ae-2961c39f2107

Files

Collections

Yayınlar - Eserler
Tıp Fakültesi